In the context of oral squamous cell carcinoma, Midkine from CAFs boosts ANRIL expression, reduces caspase-3 levels, and stimulates the expression of MRP1 and ABCC2, thereby influencing the apoptotic landscape (80). Here, CDKN2B-AS1 is linked to oral cavity squamous cell carcinoma.